Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease?
2011

Leucine-rich repeat kinase 2 and alpha-synuclein: pathways in Parkinson's disease

publication Evidence: moderate

Author Information

Author(s): Greggio Elisa, Bisaglia Marco, Civiero Laura, Bubacco Luigi

Primary Institution: Department of Biology, University of Padova

Hypothesis

What are the experimental data supporting a common molecular pathway for dominant PD genes?

Conclusion

The study suggests that LRRK2 and alpha-synuclein may interact and influence each other's pathological roles in Parkinson's disease.

Supporting Evidence

  • Mutations in LRRK2 are linked to both familial and sporadic forms of Parkinson's disease.
  • Alpha-synuclein is a major component of Lewy bodies, which are characteristic of Parkinson's disease.
  • Phosphorylation of alpha-synuclein may influence its aggregation and toxicity.

Takeaway

This study looks at two proteins, LRRK2 and alpha-synuclein, to see how they might work together to cause Parkinson's disease.

Methodology

The review discusses recent literature on LRRK2 and alpha-synuclein, focusing on their roles in Parkinson's disease.

Limitations

The review is based on existing literature and may not include all recent findings.

Digital Object Identifier (DOI)

10.1186/1750-1326-6-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication